Tag: biotech

  Human papillomavirus (HPV), a common sexually transmitted infection, can beget a wide range of health problems including genital warts and cancers. Development of HPV vaccine is a major advance in guarding people against the contagion. The first HPV vaccine, Gardasil, was approved by the US Food and Drug Administration (FDA) in 2006. This vaccine protects against several HPV strains (e.g., 6, 11, 16, and 18) known to induce cervical cancer and genital clods.   The development of HPV vaccines is a complex and grueling process that requires time for exploration and testing. Researchers…

Read More

  Gene delivery is a therapeutic strategy that’s revolutionizing biotechnology and pharmaceuticals. It involves the delivery of new genetic molecules into target cells to treat diseases. This technology has the implicit to revise the treatment of inherited genetic disorders, cancer and other intractable driseases.   Scientists are using a variety of gene delivery strategies to insert new genes into cells. One common biological system is viral gene delivery, where the viral vectors are modified to carry the genes and deliver them to the target cells. The vectors have been used…

Read More

  Alfa Cytology has announced its molecular biology services for TME research.   Alfa Cytology, a specialized biotechnology company headquartered in the United States, focusing on tumor microenvironment (TME), has announced its molecular biology services for TME research. The launch of the service indicates that the company is developing towards precision and depth in TME research.   TME refers to the surrounding environment of tumor cells, which feed the latter as normal cells, molecules, and blood vessels. They make an influence on each other closely. Analyzing the biological components in…

Read More

  Ongoing research and inventions in the field of oncology focus on the development of small molecule drug therapies for use in brain tumor resection. Small molecule drugs are being developed to target and effectively treat brain tumors to improve therapeutic outcomes. Small particles containing compounds that can enter cells and interact with specific targets to inhibit or modulate their function hold promise for drug development.   Small molecule drugs are crucial for targeting the molecular pathways and signaling mechanisms involved in the growth and development of brain tumors. These…

Read More

    The development of monoclonal antibodies (mAbs) has completely transformed the field of medicine, providing targeted antidotes against a wide range of diseases, including cancer, autoimmune and infectious diseases. These therapeutic antibodies aim to specifically target antigens on the surface of cells and bind to them, leading to acidic reactions that result in the destruction of target cells.   The process of developing monoclonal antibodies (e.g. breast cancer antibodies) begins with the identification of a suitable target antigen. This can be a protein or patch that is overexpressed on…

Read More

  Alfa Cytology announced its pancreatic cancer research services for anticancer therapy in the early preclinical stages.   Alfa Cytology, a premier contract research organization, recently launched its full-scale pancreatic cancer research services with robust platforms, powerful analytics, and cross-platform collaborations.   Pancreatic cancer (PC) is a severe disease that is difficult to diagnose in the early stages due to its complex and hidden nature. Studies found that the incidence rate of PC has been increasing each year, especially in people over 45 years old. Even young patients suffering from PC…

Read More